Publications
5532 Results
- Journal / Conference
- American Society of Clinical Oncology 15:397(#1202)
- Year
- 1996
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9207
Edatrexate and carboplatin in stage IV non-small cell lung cancer: Phase II trial of the Southwest Oncology Group (SWOG).
- Journal / Conference
- American Society of Clinical Oncology 15:438(#1363)
- Year
- 1996
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-9228
Phase II trial of recombinant human interleukin-4 (rhuIL-4) in patients with disseminated malignant melanoma: A Southwest Oncology Group (SWOG) study.
- Journal / Conference
- American Society of Clinical Oncology 15:259(#672)
- Year
- 1996
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-9230
Phase II trial of recombinant human interleukin-4 (rhuIL-4) in patients with disseminated renal cell adenocarcinoma: A Southwest Oncology Group (SWOG) study.
- Journal / Conference
- American Society of Clinical Oncology 15:245(#618)
- Year
- 1996
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-9235
Phase II trial of casodex in advanced prostate cancer (CaP) patients who failed conventional hormonal manipulation: A Southwest Oncology Group (SWOG) study (SWOG9235).
- Journal / Conference
- American Society of Clinical Oncology 15:280(#755)
- Year
- 1996
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-9238 (INT-0134) (GOG-134) (NCCTG-92-61-51)
A randomized trial of paclitaxel (T) at 2 dose levels and filgrastim (G; G-CSF) at 2 doses in platinum (P) pretreated epithelial ovarian cancer (OVCA): A Gynecologic Oncology Group, SWOG, NCCTG and ECOG study.
- Journal / Conference
- American Society of Clinical Oncology 15:107(#92)
- Year
- 1996
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-9248
A phase II trial of paclitaxel in patients with metastatic refractory carcinoma of the breast: A Southwest Oncology Group (SWOG) study.
- Journal / Conference
- American Society of Clinical Oncology 15:123(#159)
- Year
- 1996
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-9314
bcl-2, p53, and response to tamoxifen in er-positive metastatic breast cancer.
- Journal / Conference
- American Society of Clinical Oncology 15:433(#1344)
- Year
- 1996
- Research Committee(s)
- Melanoma
Gender differences and independent predictors of survival in patients with metastatic malignant melanoma on SWOG trials.
- Journal / Conference
- American Society of Clinical Oncology 15:99(#63)
- Year
- 1996
- Research Committee(s)
- Breast
Metastatic breast cancer (MBC) in complete remission (CR): Observation versus CMFPTH maintenance: An ECOG randomized study.
- Journal / Conference
- Cancer Biotherapy & Radiopharmaceuticals 11(2):119-123
- Year
- 1996
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8955